Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
720 8th Ave S
Suite 100
Seattle, WA 98104Phone+1 206-788-3745
Education & Training
University of WashingtonResidency, Family Medicine, 2001 - 2003
Oregon Health & Science University (OHSU Health)Internship, Family Medicine, 2000 - 2001
Xian Medicine UniversityClass of 1982
Certifications & Licensure
WA State Medical License 2003 - 2025- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
Publications & Presentations
PubMed
- Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis.Mei Lu, Loralee B Rupp, Christina Melkonian, Sheri Trudeau, Yihe G Daida
Advances in Therapy. 2024-06-01 - Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis.Mei Lu, Loralee B Rupp, Christina Melkonian, Sheri Trudeau, Yihe G Daida
Advances in Therapy. 2024-02-01 - 16 citationsSustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.Jia Li, Stuart C. Gordon, Loralee B Rupp, Talan Zhang, Sheri Trudeau
Liver International. 2019-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
